Czechia, Jan. 6 -- Czechia based PHARMOS, a.s. has secured contract from Revmatologicky ustav for Antineoplastic and immunomodulating agents - Drug deliveries - Filgotinib 2025 (JYSELECA). The value of the contract is worth 4013700000 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....